Presented by Ali Bazarbachi, MD, PhD, Professor of Medicine, Associate Dean for Basic Research, Director, Bone Marrow Transplantation Program, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, and Andrew D. Zelenetz, MD, PhD, Professor of Medicine, Weill Medical College of Cornell University, and Vice Chair, Medical Informatics, Department of Medicine, and Attending Physician in the Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York City, New York.
J Natl Compr Canc Netw. 2014 May;12(5 Suppl):838-41. doi: 10.6004/jnccn.2014.0203.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) describe a continuum of cancer care in the United States, from initial diagnosis through treatment and referral to hospice beyond treatment. However, in many other countries, there are no regional or national clinical practice guidelines. In 2008, the NCCN-MENA (Middle East and North Africa) project was launched to adapt the NCCN Guidelines to this part of the world. During their joint presentation at the NCCN 19th Annual Conference, Dr. Ali Bazarbachi and Dr. Andrew D. Zelenetz explored the modification process of NCCN Guidelines for MENA and shared examples of how it improved the care of patients with adult T-cell leukemia or lymphoma and younger patients with diffuse large B-cell lymphoma-regardless of where they live.
美国国家综合癌症网络（NCCN）临床实践指南（NCCN 指南）描述了美国从初始诊断到治疗和治疗后转介到临终关怀的癌症治疗连续过程。然而，在许多其他国家，没有区域或国家临床实践指南。2008 年，NCCN-MENA（中东和北非）项目启动，旨在将 NCCN 指南应用于该地区。在第 19 届 NCCN 年会上，Ali Bazarbachi 博士和 Andrew D. Zelenetz 博士联合展示了 NCCN 指南在 MENA 的修订过程，并分享了它如何改善成人 T 细胞白血病或淋巴瘤患者以及年轻弥漫性大 B 细胞淋巴瘤患者的护理的例子，无论他们居住在哪里。
